Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

Addition of short-course IFNγ to standard treatment significantly increased the rate of clearance of cryptococcal infection from the CSF, and was not associated with any increase in adverse events. Two doses of IFNγ are as effective as six doses.